$MGNX Income Statement | Understand Stock

$MGNX

$2.44 +$0.25 (11.42%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Collaborative and other agreements
Revenue from government agreements
Contract manufacturing
Product sales, net
Royalty revenue
Total revenues
Costs and expenses:
Cost of product sales
Cost of manufacturing services
Research and development
Selling, general and administrative
Total costs and expenses
Loss from operations
Gain on royalty monetization arrangement
Gain on sale of MARGENZA
Interest and other income
Interest and other expense
Loss before income taxes
Income tax (benefit) expense
Net loss
Other comprehensive income (loss):
Unrealized gain (loss) on investments
Comprehensive loss
Basic net loss per common share (in usd per share)
Diluted net loss per common share (in usd per share)

Basic and diluted net loss per common share, basic (in dollars per share)
Basic and diluted net loss per common share, diluted (in dollars per share)
Basic weighted average number of common shares outstanding (in shares)
Diluted weighted average number of common shares outstanding (in shares)

Comments